EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer

Shorouk Makhlouf, Maryam Althobiti, Michael Toss, Abir A Muftah, Nigel P Mongan, Andrew H S Lee, Andrew R Green, Emad A Rakha

Modern Pathology · 2023-10 · 36 (10) · 100284

DOI: 10.1016/j.modpat.2023.100284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023-10. Verfasst von Shorouk Makhlouf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Estrogen Receptor alpha, Receptors, Estrogen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education and Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogen receptor (ER) status in breast cancer (BC) is determined using immunohistochemistry (IHC) with nuclear expression in ≥1% of cells defined as ER-positive. BC with 1%-9% expression (ER-low-positive), is a clinically and biologically unique subgroup. In this study, we hypothesized that ER-low-positive BC represents a heterogeneous group with a mixture of ER-positive and ER-negative tumor, which may explain their divergent clinical behavior. A large BC cohort (n = 8171) was investigated and categorized into 3 groups: ER-low-positive (1%-9%), ER-positive (≥10%), and ER-negative (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorEstrogen Receptor alphaReceptors, EstrogenHumansFemaleMiddle AgedImmunohistochemistryAgedAdult

Stichwörter der Autor:innen

assessmentbreast cancerestrogen receptorlow expressionpitfalls

Substanzen

Biomarkers, TumorEstrogen Receptor alphaReceptors, EstrogenESR1 protein, human

Autor:innen und Institutionen

  • Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Department of Pathology, Faculty of Medicine, Assiut…
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
  • Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Department of Histopathology, Sheffield Teaching Hosp…
  • Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya.
  • Biodiscovery Institute, School of Veterinary Medicine and Sciences, University of Nottingham, Nottingham, United Kingdom; Department of Pharmacology, Weill Cornell Medicine, New York, New York.
  • Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

Förderung

  • Ministry of Higher Education and Scientific Research

Zitieren

APA

Makhlouf, S., Althobiti, M., Toss, M., Muftah, A. A., Mongan, N. P., Lee, A. H. S., Green, A. R., & Rakha, E. A. (2023). The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer. Modern Pathology, 36(10), 100284. https://doi.org/10.1016/j.modpat.2023.100284

Vancouver

Makhlouf S, Althobiti M, Toss M, Muftah AA, Mongan NP, Lee AHS, et al. The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer. Modern Pathology. 2023;36(10):100284. doi:10.1016/j.modpat.2023.100284

BibTeX
@article{Makhlouf2023,
  author = {Makhlouf, Shorouk and Althobiti, Maryam and Toss, Michael and Muftah, Abir A and Mongan, Nigel P and Lee, Andrew H S and Green, Andrew R and Rakha, Emad A},
  title = {The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer},
  journal = {Modern Pathology},
  year = {2023},
  volume = {36},
  number = {10},
  pages = {100284},
  doi = {10.1016/j.modpat.2023.100284}
}
Kostenlos starten →